Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells (Q39847613)

15 September 2017

Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells (English)

1 reference

15 September 2017

1 reference

6

W Wick

1 reference

15 September 2017

D Gramatzki

1

1 reference

15 September 2017

G Pantazis

2

1 reference

15 September 2017

J Schittenhelm

3

1 reference

15 September 2017

G Tabatabai

4

1 reference

15 September 2017

C Köhle

5

1 reference

15 September 2017

M Schwarz

7

1 reference

15 September 2017

M Weller

8

1 reference

15 September 2017

I Tritschler

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

25 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

2593-2605

1 reference

15 September 2017

28

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.104

15 September 2017

0 references

cites work

A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The PAS superfamily: sensors of environmental and developmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

A constitutively active arylhydrocarbon receptor induces growth inhibition of jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Functional analysis of the human cytochrome P4501A1 (CYP1A1) gene enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl induces distinct patterns of gene expression between hepatoma and glioma cells: chromatin remodeling as a mechanism for selective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Functional role of AhR in the expression of toxic effects by TCDD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Regulation of TGF-beta signaling and its roles in progression of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Intrinsic AhR function underlies cross-talk of dioxins with sex hormone signalings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Dioxin receptor is a ligand-dependent E3 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Modulation of oestrogen receptor signalling by association with the activated dioxin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Overexpression of latent transforming growth factor-beta binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Human Smad3 and Smad4 are sequence-specific transcription activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.104

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.104

1 reference

15 September 2017

1 reference